CXCL12/SDF-1 Antibody MAB350-100 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemCXCL12/SDF-1 Antibody
CompanyR&D Systems, a Bio-Techne Brand
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberMAB350-100
PurityProtein A or G purified from hybridoma culture supernatant
Brand/TrademarkR&D Systems, a Bio-Techne Brand
Antibody TypePrimary Antibodies
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution
ReactivityHu, Ms
ClonalityMonoclonal
NCBI Gene AliasesIRH, PBSF, SCYB12, SDF1, TLSF, TPAR1
NCBI Full Gene NameC-X-C motif chemokine ligand 12
ApplicationsELISA-cap, FCM, ICC, IHC, ISH, MC
ImmunogenE. coli-derived recombinant human CXCL12/SDF-1 alpha, Lys22-Lys89, Accession # Q6ICW0
HostMouse
Clone79018
IsotypeIgG1
TargetCXCL12/SDF-1
FormatLyophilized from a 0.2 µm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS
Conjugate/TagUnconjugated
Quantity100 ug (also 500 ug, 25 ug)

Specifications/Features

Available conjugates: Unconjugated

Specificity: Detects human and mouse CXCL12/SDF-1 alpha and CXCL12/SDF-1 beta in ELISAs

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) Macrophage fusion event as one prerequisite for inorganic nanoparticle-induced antitumor responseScience advancesJuly 21, 2023Chen S, Xing Z, Geng M, Zhao R, Yang X, Zhu X, Anderson JM, Zhang X.anti-goat STXBP6 (NB100-1227, Novus, USA), anti-rabbit TSLP (ab188766, Abcam, UK), anti-mouse CXCL12 (MAB350-100, Novus, USA), and anti-mouse SMPDL3B (sc-137113, Santa, USA). For IF staining, tumor sections dried

(2) Novel characterization of CXCR4 expressing cells in uninfected and herpes simplex virus-1 infected corneasThe ocular surfaceApril 1, 2023Suvas PK, Setia M, Rana M, Chakraborty A, Suvas S.

(3) Molecular Profiling of Tissue Samples with Chronic Rejection from Patients with Chronic Lung Allograft Dysfunction: A Pilot Study in Cystic Fibrosis PatientsBiomoleculesJanuary 3, 2023Lunardi F, Abbrescia DI, Vedovelli L, Pezzuto F, Fortarezza F, Comacchio GM, Guzzardo V, Ferrigno P, Loy M, Giraudo C, et al.

(4) CXCR4-CXCL12-CXCR7 and PD-1/PD-L1 in Pancreatic Cancer: CXCL12 Predicts Survival of Radically Resected PatientsCellsOctober 22, 2022D'Alterio C, Giardino A, Scognamiglio G, Butturini G, Portella L, Guardascione G, Frigerio I, Montella M, Gobbo S, Martignoni G, et al.

(5) Meteorin links the bone marrow hypoxic state to hematopoietic stem/progenitor cell mobilizationCell reportsSeptember 20, 2022Dai YW, Ma JK, Jiang R, Zhan XL, Chen SY, Feng LL, Zhang Q, Liang TB, Lv K, Yang GJ, et al.

(6) Peripheral apoE4 enhances Alzheimer's pathology and impairs cognition by compromising cerebrovascular functionNature neuroscienceAugust 1, 2022Liu CC, Zhao J, Fu Y, Inoue Y, Ren Y, Chen Y, Doss SV, Shue F, Jeevaratnam S, Bastea L, et al.

(7) A stromal Integrated Stress Response activates perivascular cancer-associated fibroblasts to drive angiogenesis and tumour progressionNature cell biologyJune 1, 2022Verginadis II, Avgousti H, Monslow J, Skoufos G, Chinga F, Kim K, Leli NM, Karagounis IV, Bell BI, Velalopoulou A, et al.

(8) Biological Role of Tumor/Stromal CXCR4-CXCL12-CXCR7 in MITO16A/MaNGO-OV2 Advanced Ovarian Cancer PatientsCancersApril 6, 2022D'Alterio C, Spina A, Arenare L, Chiodini P, Napolitano M, Galdiero F, Portella L, Simeon V, Signoriello S, Raspagliesi F, et al.

(9) Cholinergic signals preserve haematopoietic stem cell quiescence during regenerative haematopoiesisNature communicationsJanuary 27, 2022Fielding C, García-García A, Korn C, Gadomski S, Fang Z, Reguera JL, Pérez-Simón JA, Göttgens B, Méndez-Ferrer S.

(10) Preservation of the naïve features of mesenchymal stromal cells in vitro: Comparison of cell- and bone-derived decellularized extracellular matrixJournal of tissue engineeringJanuary 1, 2022Pereira AR, Trivanović D, Stahlhut P, Rudert M, Groll J, Herrmann M.

(11) Stimulated Expression of CXCL12 in Adrenocortical Carcinoma by the PPARgamma Ligand Rosiglitazone Impairs Cancer ProgressionJournal of personalized medicineOctober 27, 2021Cantini G, Fei L, Canu L, Lazzeri E, Sottili M, Francalanci M, Angelotti ML, De Filpo G, Ercolino T, Gelmini S, et al.

(12) Microbiota-derived lactate promotes hematopoiesis and erythropoiesis by inducing stem cell factor production from leptin receptor+ niche cellsExperimental & molecular medicineSeptember 1, 2021Lee YS, Kim TY, Kim Y, Kim S, Lee SH, Seo SU, Zhou BO, Eunju O, Kim KS, Kweon MN.

(13) Plasma cell dynamics in the bone marrow nicheCell reportsFebruary 9, 2021Benet Z, Jing Z, Fooksman DR.,R&D Systems,Cat# MAB310500; RRID:AB_2276927 Mouse monoclonal anti-CXCL12/SDF-1 (clone 79018),R&D Systems,Cat# MAB350100; RRID:AB_2088149 Mouse monoclonal IgG1 Isotype Control (clone 11711),R&D Systems,Cat# MAB002; RRID:AB_357344 Goat

(14) CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune responseProceedings of the National Academy of Sciences of the United States of AmericaNovember 17, 2020Biasci D, Smoragiewicz M, Connell CM, Wang Z, Gao Y, Thaventhiran JED, Basu B, Magiera L, Johnson TI, Bax L, et al.

(15) New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal CancerCancersJuly 18, 2020D'Alterio C, Zannetti A, Trotta AM, Ieranò C, Napolitano M, Rea G, Greco A, Maiolino P, Albanese S, Scognamiglio G, et al.

(16) SOX4 activates CXCL12 in hepatocellular carcinoma cells to modulate endothelial cell migration and angiogenesis in vivoOncogeneJune 1, 2020Tsai CN, Yu SC, Lee CW, Pang JS, Wu CH, Lin SE, Chung YH, Tsai CL, Hsieh SY, Yu MC.

(17) The lymph node stromal laminin α5 shapes alloimmunityThe Journal of clinical investigationMay 1, 2020Li L, Shirkey MW, Zhang T, Xiong Y, Piao W, Saxena V, Paluskievicz C, Lee Y, Toney N, Cerel BM, et al.

(18) Prognostic Value of SDF-1α Expression in Patients with Esophageal Squamous Cell Carcinoma Receiving EsophagectomyCancersApril 25, 2020Chen YH, Li SH, Lu HI, Lo CM.properties of ESCC cells, we treated these ESCC cell lines with chemotherapeutic agents (cisplatin), SDF-1α (MAB350, 100 ng/mL, R&D Systems), and AMD3100 (Sigma-Aldrich, Saint Louis, MO, USA). Each cell line (2500 cells)

(19) Involvement of CXCL12/CXCR4 in the motility of human first-trimester endometrial epithelial cells through an autocrine mechanism by activating PI3K/AKT signalingBMC pregnancy and childbirthFebruary 10, 2020Zheng J, Qu D, Wang C, Ding L, Zhou W.

(20) Engineered scaffolds based on mesenchymal stem cells/preosteoclasts extracellular matrix promote bone regenerationJournal of tissue engineeringJanuary 1, 2020Dong R, Bai Y, Dai J, Deng M, Zhao C, Tian Z, Zeng F, Liang W, Liu L, Dong S.

Be the First to Write a Review!

CXCL12/SDF-1 Antibody

CXCL12/SDF-1 Antibody

CXCL12/SDF-1 Antibody

CXCL12/SDF-1 Antibody

CXCL12/SDF-1 Antibody

CXCL12/SDF-1 Antibody from R&D Systems, a Bio-Techne Brand

Specifications/Features

R&D Systems, a Bio-Techne Brand

Citations (91)

Reviews

CXCL12/SDF-1 Antibody from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map